Daré Bioscience, Inc.
DARE
$1.75
$0.031.45%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -384.47% | -158.33% | 94.19% | 86.56% | 91.22% |
| Total Depreciation and Amortization | 2,310.68% | 1,294.07% | 377.58% | 10.16% | 17.69% |
| Total Amortization of Deferred Charges | 520.55% | -47.03% | 5,428.57% | -- | -- |
| Total Other Non-Cash Items | 3.24% | 5.06% | 9.98% | 112.12% | -12.87% |
| Change in Net Operating Assets | 212.29% | 172.03% | 277.00% | 155.55% | -497.33% |
| Cash from Operations | 23.81% | -15.15% | 122.80% | 113.88% | 78.10% |
| Capital Expenditure | -20.06% | 69.15% | -13.55% | 8.96% | -2,389.92% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -20.06% | 69.15% | -13.55% | 8.96% | -2,389.92% |
| Total Debt Issued | -13.35% | -6.57% | -6.57% | -6.57% | -6.57% |
| Total Debt Repaid | -149.19% | -69.74% | -5.91% | -73.41% | -343.41% |
| Issuance of Common Stock | 1,564.90% | -89.60% | -92.94% | -95.74% | -87.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.01% | -100.01% | -100.08% | -100.05% | -- |
| Cash from Financing | 218.65% | -96.38% | -95.36% | -97.23% | -43.11% |
| Foreign Exchange rate Adjustments | -158.52% | -191.05% | 41.79% | -607.29% | -48.83% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 539.12% | -473.02% | 142.01% | 121.74% | 89.69% |